Time to read
1 minute
Read so far

Machine learning predicts anti-cancer drug efficacy for CRC patients

Tue, 11/03/2020 - 11:55
Posted in:

A research team led by Professor Sanguk Kim in the Department of Life Sciences at POSTECH has successfully increased the accuracy of anti-cancer drug response predictions by using data closest to a real person's response. The team developed this machine learning technique through algorithms that learn the transcriptome information from artificial organoids derived from actual patients instead of animal models. These research findings, ‘Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients’, were published in the international journal Nature Communications.

Even patients with the same cancer have different reactions to anti-cancer drugs so customised treatment is considered paramount in treatment development. However, the current predictions were based on genetic information of cancer cells, limiting their accuracy. Due to unnecessary biomarker information, machine learning had an issue of learning based on false signals.

To increase the predictive accuracy, the research team introduced machine learning algorithms that use protein interaction network that can interact with target proteins as well as the transcriptome of individual proteins that are directly related with drug targets. It induces learning the transcriptome production of a protein that is functionally close to the target protein. Through this, only selected biomarkers can be learned instead of false biomarkers that the conventional machine learning had to learn, which increases the accuracy.

In addition, data from patient-derived organoids - not animal models - were used to narrow the discrepancy of responses in actual patients. With this method, colorectal cancer patients treated with 5-fluorouracil and bladder cancer patients treated with cisplatin were predicted to be comparable to actual clinical results.

To access this paper, please click here